Low Waste Syringe and Needle

A low-dead-space syringe and needle platform that improves dosing precision and reduces drug waste in high-value injectable therapies.

  1. General Details

    AccuSave is a patented low-dead-space syringe and interchangeable needle system designed to reduce medication waste and improve dosing precision in high-value injectable therapies. Built on a proprietary reverse Luer-lock architecture with an integrated obturating needle spike, it minimizes dead space in both the syringe tip and needle hub, improving drug delivery efficiency compared to conventional syringe designs.

    Optimized for neurotoxin injections such as Botox, AccuSave is also compatible with dermal fillers, vaccines, biologics, GLP-1 medications, and other high-cost injectable liquids and gels.

    Unlike standard 1cc and insulin syringes adapted from general medical use, AccuSave is engineered for unit dosing accuracy, ergonomic handling, secure needle interchangeability, and reduced product loss at the point of injection. With granted multi-jurisdictional patent protection, it represents a next-generation drug delivery platform that improves efficiency, reduces cost per dose, and advances standards in injectable administration.

  2. Patent Portfolio

    The IP and assets available for sale include:

    • US10780229, US11980745, 61/774,297, 62/063,763, 62/019,072, EP2964295, MX377201, CN105263544, ES2944564, BR112015021969, JP2016508853, WO2014138634, CA2908822, MX2020011879, JP6786456, JP7110295, US20240245864, WO2016003981, JP 2015-561726
    • USPTO trademark serial number 99650969 – “ACCUSAVE”
    • Domain name and website AccuSaveSyringe.com
  3. Data Room Access & Additional Details

    Other Public Data Room Materials Available at VIP-3591 Public Data Room for Low Waste Syringe and Needle IP:

    • Introductory Materials
    • Patents, Applications, and Trademark
    • Patents, Applications, and Trademark File Histories
    • Patent Assignment and Ownership
    • Technology Summary

    Additional Materials (available upon signing a mutual non-disclosure agreement):

    • Due Diligence Review
    • Deck
  4. More Information

    Pricing guidance for this transaction may be available. All parties interested in the IP above are authorized to contact Charlette Hunter at Vibrant IP, LLC at charlette@vibrantip.com and +1 404-482-3652.